Profile data is unavailable for this security.
About the company
UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components.
- Revenue in USD (TTM)602.80m
- Net income in USD68.31m
- Incorporated1993
- Employees4.15k
- LocationUFP Technologies Inc100 Hale StreetNEWBURYPORT 01950United StatesUSA
- Phone+1 (302) 636-5400
- Websitehttps://www.ufpt.com/
More ▼
Mergers & acquisitions
| Acquired company | UFPT:NAQ since announced | Transaction value |
|---|---|---|
| Techno Plastics Industries Inc | -11.93% | -- |
| Universal Plastics Corp | -11.93% | -- |
Data delayed at least 15 minutes, as of Mar 03 2026 20:19 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | 350.00k | -72.78m | 1.28bn | 116.00 | -- | 15.85 | -- | 3,661.70 | -1.08 | -1.08 | 0.0052 | 1.19 | 0.0031 | -- | -- | 3,017.24 | -64.12 | -74.23 | -69.64 | -82.45 | -54.00 | -- | -20,794.57 | -11,780.43 | 10.51 | -- | 0.00 | -- | -- | -- | -35.82 | -- | -5.35 | -- |
| Adapthealth Corp | 3.24bn | -70.27m | 1.31bn | 10.90k | -- | 0.8599 | 3.96 | 0.4038 | -0.5224 | -0.5224 | 23.84 | 11.21 | 0.7372 | 17.60 | 8.33 | 297,693.30 | -1.50 | -1.84 | -1.76 | -2.08 | 21.07 | 20.27 | -2.04 | -2.74 | 0.8109 | 1.96 | 0.5393 | -- | -0.4943 | 25.16 | -185.55 | -- | 57.26 | -- |
| Iradimed Corp | 83.81m | 22.48m | 1.32bn | 160.00 | 59.30 | 13.95 | 78.44 | 15.75 | 1.75 | 1.75 | 6.52 | 7.44 | 0.8094 | -- | -- | -- | 21.71 | 18.06 | 23.86 | 20.21 | 76.75 | 76.85 | 26.82 | 25.51 | -- | -- | -- | -- | 14.43 | 21.45 | 16.88 | 108.61 | -- | -- |
| Kestra Medical Technologies Ltd | 74.26m | -138.79m | 1.33bn | 330.00 | -- | 7.13 | -- | 17.88 | -2.76 | -2.76 | 1.47 | 3.19 | 0.4034 | -- | 9.40 | 225,027.30 | -71.43 | -122.23 | -92.37 | -192.35 | 46.40 | -- | -177.06 | -342.51 | -- | -116.72 | 0.2033 | -- | 115.05 | -- | -25.08 | -- | 150.61 | -- |
| Conmed Corp | 1.37bn | 47.06m | 1.41bn | 3.90k | 30.27 | 1.37 | 11.64 | 1.03 | 1.51 | 1.51 | 44.20 | 33.36 | 0.5936 | 1.78 | 5.66 | 352,493.60 | 2.03 | 2.11 | 2.33 | 2.41 | 54.59 | 54.98 | 3.42 | 3.78 | 1.01 | 3.30 | 0.447 | 51.06 | 5.18 | 9.77 | -64.47 | 37.66 | 8.76 | -5.59 |
| Procept Biorobotics Corp | 308.05m | -95.57m | 1.46bn | 888.00 | -- | 3.99 | -- | 4.74 | -1.72 | -1.72 | 5.55 | 6.50 | 0.5912 | 1.76 | 3.69 | 346,907.70 | -18.34 | -23.13 | -20.70 | -25.70 | 63.70 | 58.76 | -31.02 | -56.52 | 5.77 | -- | 0.1236 | -- | 37.22 | 109.04 | -4.55 | -- | 109.29 | -- |
| Enovis Corp | 2.25bn | -1.18bn | 1.47bn | 7.80k | -- | 0.9868 | -- | 0.6544 | -20.69 | -20.72 | 39.39 | 26.05 | 0.5256 | 1.66 | 5.29 | 288,137.50 | -27.63 | -7.98 | -31.84 | -9.05 | 58.16 | 56.87 | -52.57 | -24.34 | 1.04 | 1.06 | 0.465 | -- | 6.66 | -6.05 | -42.80 | -- | 11.45 | -- |
| Novocure Ltd | 655.35m | -136.23m | 1.54bn | 1.61k | -- | 4.47 | -- | 2.35 | -1.22 | -1.22 | 5.88 | 3.03 | 0.6409 | 4.35 | 8.01 | 408,319.60 | -13.32 | -11.74 | -25.57 | -15.63 | 74.73 | 76.71 | -20.79 | -23.31 | 2.71 | -- | 0.3642 | -- | 8.28 | 5.80 | 19.21 | -- | 12.23 | -- |
| Quidelortho Corp | 2.73bn | -1.13bn | 1.54bn | 6.50k | -- | 0.799 | -- | 0.5636 | -16.66 | -16.66 | 40.25 | 28.28 | 0.4478 | 2.62 | 7.12 | 420,030.80 | -18.56 | -6.45 | -22.13 | -7.39 | 46.67 | 53.89 | -41.45 | -14.40 | 0.9002 | 0.3677 | 0.5798 | -- | -1.89 | 10.44 | 44.84 | -- | 23.72 | -- |
| AtriCure Inc | 534.53m | -11.45m | 1.54bn | 1.35k | -- | 3.13 | 169.62 | 2.88 | -0.241 | -0.241 | 11.19 | 9.88 | 0.8461 | 1.74 | 8.42 | 395,946.70 | -1.81 | -2.67 | -2.07 | -2.98 | 74.98 | 74.88 | -2.14 | -4.13 | 2.99 | -6.75 | 0.1232 | -- | 14.88 | 20.95 | 74.39 | -- | 23.40 | -- |
| UFP Technologies Inc | 602.80m | 68.31m | 1.58bn | 4.15k | 23.28 | 3.72 | 18.02 | 2.61 | 8.78 | 8.78 | 77.44 | 54.96 | 0.9389 | 4.96 | 7.19 | -- | 10.64 | 10.57 | 12.06 | 12.07 | 28.27 | 27.60 | 11.33 | 11.12 | 1.52 | 9.46 | 0.2422 | -- | 19.50 | 27.43 | 15.82 | 38.57 | -- | -- |
| AxoGen Inc | 225.21m | -15.70m | 1.59bn | 622.00 | -- | 11.23 | -- | 7.06 | -0.3413 | -0.3413 | 4.77 | 2.73 | 1.06 | 1.53 | 8.96 | 362,070.80 | -7.38 | -10.17 | -8.46 | -11.70 | 74.31 | 77.27 | -6.97 | -12.34 | 3.31 | -0.9786 | 0.2732 | -- | 20.21 | 14.93 | -57.60 | -- | -24.36 | -- |
| Tandem Diabetes Care Inc | 1.01bn | -204.71m | 1.72bn | 2.50k | -- | 11.10 | -- | 1.70 | -3.07 | -3.07 | 15.08 | 2.27 | 1.10 | 3.37 | 7.25 | 405,894.40 | -22.15 | -12.88 | -30.13 | -16.00 | 53.81 | 52.12 | -20.17 | -14.32 | 2.02 | -6.00 | 0.6699 | -- | 7.93 | 15.26 | -113.18 | -- | -9.19 | -- |
| Artivion Inc | 441.33m | 9.76m | 1.85bn | 1.80k | 194.04 | 4.11 | 57.28 | 4.18 | 0.1987 | 0.1987 | 9.44 | 9.37 | 0.5273 | 1.82 | 5.22 | 245,183.30 | 1.17 | -1.72 | 1.30 | -1.86 | 64.40 | 64.69 | 2.21 | -3.80 | 2.62 | 1.44 | 0.3278 | -- | 13.59 | 11.75 | 173.17 | -- | 39.74 | -- |
| Inspire Medical Systems Inc | 911.98m | 145.42m | 1.85bn | 1.33k | 13.04 | 2.37 | 11.62 | 2.03 | 4.97 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | 684,156.80 | 16.95 | 3.09 | 19.00 | 3.48 | 85.39 | 84.83 | 15.95 | 3.05 | 4.56 | -- | 0.00 | 0.00 | 13.60 | 51.21 | 171.77 | -- | 73.41 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.87bn | 3.58k | 954.42 | 1.51 | 22.89 | 1.58 | 0.0432 | 0.0432 | 25.70 | 27.36 | 0.5786 | 7.19 | 5.01 | 330,962.30 | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.88 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | 0.00 | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
Data as of Mar 03 2026. Currency figures normalised to UFP Technologies Inc's reporting currency: US Dollar USD
55.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.02m | 13.20% |
| Wasatch Advisors LPas of 30 Jan 2026 | 782.71k | 10.15% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 471.54k | 6.12% |
| Congress Asset Management Co. LLPas of 31 Dec 2025 | 441.12k | 5.72% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2025 | 309.67k | 4.02% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 289.78k | 3.76% |
| American Century Investment Management, Inc.as of 31 Dec 2025 | 267.13k | 3.46% |
| Thrivent Asset Management LLCas of 31 Dec 2025 | 248.13k | 3.22% |
| Boston Trust Walden, Inc.as of 31 Dec 2025 | 232.68k | 3.02% |
| UBS Securities LLCas of 31 Dec 2025 | 187.91k | 2.44% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
